Pharma IP Circle

A niche blog dedicated to "Drug Patent Litigation Decisions" across major jurisdictions

Saturday, December 29, 2018

Metformin & Pioglitazone - USA

›
Decision on IPR: Dec 28, 2018 AIA Review Filing Date Institution Date Petitioner US Patent ...
Saturday, December 22, 2018

Dexmedetomidine – USA

›
On Dec 17, an Illinois federal judge invalidated two patents covering a “ready-to-use” version of Hospira Inc.’s sedation drug Precedex. ...
Friday, December 21, 2018

Trastuzumab - USA

›
Decision on IPR: Nov 20, 2018 AIA Review Filing Date Institution Date Petitioner US Patent ...

Patisiran - USA

›
Decision on PGR: Nov 20, 2018 AIA Review Filing Date Institution Date Petitioner US Patent...
Thursday, December 20, 2018

Patisiran - USA

›
Decision on PGR: Nov 19, 2018 AIA Review Filing Date Institution Date Petitioner US Patent ...
Wednesday, December 19, 2018

Insulin product(s) - USA

›
Decision on IPR: Nov 19, 2018 AIA Review Filing Date Institution Date Petitioner US Patent ...

Tiotropium - Netherlands

›
On Dec 11, 2018, Court of Appeal affirmed the district court’s judgment that amended claims of patent covering inhalation capsule lack in...
Monday, December 17, 2018

Vilanterol & Umeclidinium - UK

›
On Dec 13, 2018, UK high court found Vectura’s patents invalid, not infringed by Glaxo & thus granted Arrow declaration. Backgro...
Saturday, December 15, 2018

Paclitaxel - CJEU

›
On Dec 13, 2018, Advocate General of Court of Justice of European Union (CJEU) opined on the issue of interpretation of Article 3(d) of S...
Thursday, December 13, 2018

Mesalamine – USA

›
On Dec 12, 2018, Federal Circuit affirmed (Rule 36 judgment) Texas district court’s decision which granted summary judgment of non-infrin...
‹
›
Home
View web version

Mahendraa

Mahendraa
View my complete profile
Powered by Blogger.